Skip to main content
OpenTrials
Completed

NCT Number: NCT05345405

Clinical Trial of a Supporter-Targeted Intervention to Improve Outcomes in Recent Sexual Assault Survivors

Communication and Recovery Enhancement (CARE) is a 2-session early intervention for survivors of recent sexual assault and their supporters that aims to improve supporters' ability to respond effectively. The goal of this pilot trial is to understand the acceptability and preliminary efficacy of two versions of CARE: a version in which survivors and supporters attend both sessions together (dyadic CARE) and a version in which supporters attend sessions alone (supporter-only CARE). Survivors aged 14+ with elevated posttraumatic stress symptoms will enroll with a supporter of their choosing. Dyads will be randomized to dyadic CARE, supporter-only CARE, or waitlist control, and will complete self-report assessments at baseline, post-session-1, and follow-ups (1, 2, and 3 months post-baseline). Results will be used to inform future changes to CARE and determine whether a fully-powered randomized controlled trial is warranted.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Stress Disorders, Post-Traumatic Behavior Help-Seeking Behavior Helping Behavior Mental Disorders Relationship, Social Sexual Assault Sexual Violence Social Behavior Social Interaction Stress Stress Disorders, Traumatic Trauma and Stressor Related Disorders

Age range

14 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Washington School of Medicine

Seattle, Washington, 98195-7238, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

(Survivors):

  • Age 14+ years
  • Can speak/read English or Spanish
  • Have access to a Zoom-capable device
  • Screened for eligibility within 10 weeks of sexual assault, defined as any unwanted, distressing sexual contact (e.g., unwanted touching, coerced sexual activity, rape)
  • Able to attend first study session within 2 weeks of screening
  • Elevated PTSD symptoms at screening as operationalized by a Primary Care PTSD Screen score of 2/5 or above
  • Able to identify an eligible supporter
  • Have a way to receive survey links and complete surveys privately (i.e., without potential device or account access by the supporter)

Inclusion criteria

(Supporters):

  • Age 14+ years
  • Can speak/read English or Spanish
  • Have access to a Zoom-capable device
  • Able to attend first study session within 2 weeks of survivor's screening
  • Are in contact with the survivor at least once a week
  • In the opinion of the survivor, are able to make an independent decision about whether or not to participate in the study
  • Have a way to receive survey links and complete surveys privately (i.e., without potential device or account access by the survivor)

Exclusion criteria

(Survivors):

  • Active psychosis
  • Active suicidal intent

Exclusion criteria

(Supporters):

  • Perpetrated the sexual assault
  • Engaged in severe past-year violence or abuse (as defined by the survivor) against the survivor
  • The survivor has not told the supporter about the sexual assault at the time of screening and was not already planning to tell the supporter
  • In the opinion of the survivor, relational conflict exists between the survivor and supporter that potentially could be exacerbated by program participation

Treatment and study plan

Dyadic CARE

Behavioral

Dyadic CARE involves two telehealth sessions with a clinician, the survivor, and a supporter of the survivor's choice. Session content uses cognitive-behavioral strategies (e.g., encouraging non-avoidance) to encourage communication and improve supporters' responses in trauma-related conversations. Between sessions, both the survivor and the supporter are instructed to review session content and have guided discussions with the assistance of a workbook.

Supporter-Only CARE

Behavioral

Supporter-only CARE involves two telehealth sessions with a clinician and a supporter of the survivor's choice, without the survivor present. Session content uses cognitive-behavioral strategies (e.g., encouraging non-avoidance) to encourage communication and improve supporters' responses in trauma-related conversations. Between sessions, both the survivor and the supporter are instructed to review session content and have guided discussions with the assistance of a workbook.

Primary outcomes

  1. Survivor Satisfaction With Intervention at 1 Month Post-baseline (Self Report)

    Time frame: 1 month

    Sum score on Client Satisfaction Scale, completed by survivor. Range: 8 to 32; higher scores indicate greater satisfaction

  2. Supporter Satisfaction With Intervention at 1 Month Post-baseline (Self Report)

    Time frame: 1 month

    Sum score on Client Satisfaction Scale, completed by supporter. Range: 8 to 32; higher scores indicate greater satisfaction

  3. Change in Survivor Knowledge at 1 Month Post-baseline (Self Report)

    Time frame: Baseline, 1 month

    Sum score on a knowledge questionnaire reflecting CARE concepts, completed by the survivor. Range: 8 to 40; higher scores indicate more knowledge about CARE concepts.

  4. Change in Supporter Knowledge at 1 Month Post-baseline (Self Report)

    Time frame: Baseline, 1 month

    Sum score on a knowledge questionnaire reflecting CARE concepts, completed by the supporter. Range: 9 to 45; higher scores indicate more knowledge about CARE concepts.

  5. Change in Survivor Confusion About Help-seeking Behavior at 1 Month Post-baseline (Self Report)

    Time frame: Baseline, 1 month

    Sum score on 4-item measure created for this study, completed by survivor. Range: 4 to 20; higher scores indicate greater confusion.

  6. Change in Supporter Confusion About Helping Behavior at 1 Month Post-baseline (Self Report)

    Time frame: Baseline, 1 month

    Sum score on the Confusion subscale of the Impact on Friends scale, completed by supporter. Range: 6 to 30; higher scores indicate greater confusion about helping behavior.

  7. Survivor Disclosure Frequency to Supporter at 1 Month Post-baseline (Self Report)

    Time frame: 1 month

    Single item representing frequency of disclosures to supporter in past month, completed by survivor, adapted from the Early Intervention Clinic Disclosure scale. Survivor will input a numerical response representing number of disclosures. Higher scores indicate more frequent disclosure.

  8. Supporter Overt Hostile Reactions to Disclosure at 1 Month Post-baseline (Informant Report)

    Time frame: 1 month

    Sum score on Turning Against subscale of the Social Reactions Questionnaire - Shortened, completed by survivor in reference to supporter's reactions in past month. Range: 0 to 24; higher scores indicate more frequent hostile negative reactions.

  9. Supporter Subtly Unsupportive Reactions to Disclosure at 1 Month Post-baseline (Informant Report)

    Time frame: 1 month

    Sum score on Unsupportive Acknowledgment subscale of the Social Reactions Questionnaire - Shortened, completed by survivor in reference to supporter's reactions in past month. Range: 0 to 24; higher scores indicate more frequent subtly unsupportive reactions.

  10. Change in Supporter Responsiveness at 1 Month Post-baseline (Informant Report)

    Time frame: Baseline & 1 month

    Sum score on the Responsiveness subscale of the Perceived Responsiveness and Insensitivity scale, completed by survivor in reference to past month. Range: 0 to 40; higher scores indicate greater responsiveness.

  11. Change in Survivor PTSD Symptom Severity at 3 Months Post-baseline (Self Report)

    Time frame: Baseline, 3 months

    Sum score on PTSD Checklist-5 (PCL-5), completed by survivor in reference to past month. Range: 0-80; higher scores indicate greater severity of PTSD symptoms.

  12. Survivor Provisional PTSD Diagnostic Status at 3 Months Post-baseline (Self Report)

    Time frame: 3 months

    Provisional PTSD diagnostic status based on PTSD Checklist-5 (PCL-5), completed by survivor in reference to past month. Survivors will be considered to have a provisional diagnosis if the following items are rated as 2 = "Moderately" or higher: one Criterion B item (questions 1-5), one Criterion C item (questions 6-7), two Criterion D items (questions 8-14), and two Criterion E items (questions 15-20).

  13. Change in Survivor Stress at 3 Months Post-baseline (Self Report)

    Time frame: Baseline, 3 months

    Sum score on the Stress subscale of the Depression and Anxiety Stress Scales (DASS-21), completed by survivor in reference to past week. Range: 0 to 21; higher scores indicate greater stress.

  14. Change in Supporter Stress at 3 Months Post-baseline (Self Report)

    Time frame: Baseline, 3 months

    Sum score on the Stress subscale of the Depression and Anxiety Stress Scales (DASS-21), completed by supporter in reference to past week. Range: 0 to 21; higher scores indicate greater stress.

  15. Change in Survivor Perceived Relationship Quality at 3 Months Post-baseline (Self Report)

    Time frame: Baseline, 3 months

    Sum score on the Relationship Assessment Scale, completed by survivor. Range: 7 to 35; higher scores indicate greater relationship quality.

  16. Change in Supporter Perceived Relationship Quality at 3 Months Post-baseline (Self Report)

    Time frame: Baseline, 3 months

    Sum score on the Relationship Assessment Scale, completed by supporter. Range: 7 to 35; higher scores indicate greater relationship quality.

Secondary outcomes

  1. Survivor Willingness to Participate in Criminal Justice Process at 1 Month Post-baseline (Self Report)

    Time frame: 1 month

    Sum score score on measure created for this study, completed by survivor. Range: 0 to 10; higher scores indicate greater willingness.

  2. Survivor Participation in Criminal Justice Process at 1 Month Post-baseline (Self Report)

    Time frame: 1 month

    Mean score on measure created for this study, completed by survivor. Range: 0 to 1; higher scores indicate greater participation.

  3. Change in Survivor Depression at 3 Months Post-baseline (Self Report)

    Time frame: Baseline, 3 months

    Sum score on the Depression subscale of the Depression and Anxiety Stress Scales (DASS-21), completed by survivor in reference to past week. Range: 0 to 21; higher scores indicate greater depression.

  4. Change in Supporter Depression at 3 Months Post-baseline (Self Report)

    Time frame: Baseline, 3 months

    Sum score on the Depression subscale of the Depression and Anxiety Stress Scales (DASS-21), completed by supporter in reference to past week. Range: 0 to 21; higher scores indicate greater depression.

  5. Change in Survivor Anxiety at 3 Months Post-baseline (Self Report)

    Time frame: Baseline, 3 months

    Sum score on the Anxiety subscale of the Depression and Anxiety Stress Scales (DASS-21), completed by survivor in reference to past week. Range: 0 to 21; higher scores indicate greater anxiety.

  6. Change in Supporter Anxiety at 3 Months Post-baseline (Self Report)

    Time frame: Baseline, 3 months

    Sum score on the Anxiety subscale of the Depression and Anxiety Stress Scales (DASS-21), completed by supporter in reference to past week. Range: 0 to 21; higher scores indicate greater anxiety.

  7. Change in Survivor Role Impairment at 3 Months Post-baseline (Self Report)

    Time frame: Baseline, 3 months

    Sum score on Work/School/Responsibility Impairment subscale of the Behavioral Activation for Depression Scale (BADS), completed by survivor in reference to past week. Range: 0 to 30; higher scores indicate more impairment.

  8. Change in Survivor Social Impairment at 3 Months Post-baseline (Self Report)

    Time frame: Baseline, 3 months

    Sum score on Social Impairment subscale of the Behavioral Activation for Depression Scale (BADS), completed by survivor in reference to past week. Range: 0 to 30; higher scores indicate more impairment.

  9. Change in Survivor Flourishing at 3 Months Post-baseline (Self Report)

    Time frame: Baseline, 3 months

    Sum score on Flourishing Index Measure, completed by survivor. Range: 0 to 120; higher scores indicate more flourishing.

  10. Change in Supporter Flourishing at 3 Months Post-baseline (Self Report)

    Time frame: Baseline, 3 months

    Sum score on Flourishing Index Measure, completed by supporter. Range: 0 to 120; higher scores indicate more flourishing.

  11. Survivor Distress Associated With Supporter Negative Reactions at 1 Month Post-baseline (Self Report)

    Time frame: 1 month

    Mean score on ratings of distress associated endorsed items on Negative Reactions subscale of the Social Reactions Questionnaire - Shortened, completed by survivor in reference to supporter's reactions to survivor in past month. Range: 0 to 3; higher scores indicate more distress.

  12. Supporter Positive Reactions to Disclosure at 1 Month Post-baseline (Informant Report)

    Time frame: 1 month

    Sum score on Positive Reactions subscale of the Social Reactions Questionnaire - Shortened, completed by survivor in reference to supporter's reactions in past month. Range: 0 to 16; higher scores indicate more frequent positive reactions.

  13. Change in Survivor Typical Alcohol Consumption (Quantity) at 3 Months Post-baseline (Self Report)

    Time frame: Baseline, 3 months

    Number of typical drinks per week in past month reported by survivor on the Daily Drinking Questionnaire

  14. Change in Survivor Typical Alcohol Consumption (Frequency) at 3 Months Post-baseline (Self Report)

    Time frame: Baseline, 3 months

    Number of typical drinking days per week in past month reported by survivor on the Daily Drinking Questionnaire. Range: 0 to 7.

  15. Change in Survivor Typical Alcohol Consumption (Hours) at 3 Months Post-baseline (Self Report)

    Time frame: Baseline, 3 months

    Number of typical drinking hours per week in past month reported by survivor on the Daily Drinking Questionnaire.

  16. Supporter Perceived Helping Ineffectiveness at 1 Month Post-baseline (Self Report)

    Time frame: 1 month

    Sum score on the Confusion subscale of the Impact on Friends measure, completed by supporter in reference to the past month. Range: 6 to 30; higher scores indicate greater perceived ineffectiveness.

  17. Supporter Distress in Helping at 1 Month Post-baseline (Self Report)

    Time frame: 1 month

    Sum score on the Emotional Distress subscale of the Impact on Friends measure, completed by supporter in reference to the past month. Range: 24 to 120; higher scores indicate greater distress.

  18. Supporter Accommodation of Survivor PTSD Symptoms at 1 Month Post-baseline (Self Report)

    Time frame: 1 month

    Sum score on the Significant Others' Responses to Trauma Scale (SORTS), completed by supporter in reference to the past month. Range: 0 to 112; higher scores indicate greater accommodation.

  19. Change in Survivor Cannabis Use Frequency at 3 Months Post-baseline (Self Report)

    Time frame: Baseline, 3 months

    Number of days of cannabis use in past 2 weeks, as reported by survivor. Range: 0 to 14.

  20. Change in Survivor Prescription Opioid Misuse Frequency at 3 Months Post-baseline (Self Report)

    Time frame: Baseline, 3 months

    Number of days of prescription opioid use not as prescribed in past 2 weeks, as reported by survivor. Range: 0 to 14.

  21. Change in Survivor Non-prescription Opioid Use Frequency at 3 Months Post-baseline (Self Report)

    Time frame: Baseline, 3 months

    Number of days of non-prescription opioid use in past 2 weeks, as reported by survivor. Range: 0 to 14.

  22. Change in Survivor Prescription Amphetamine Misuse Frequency at 3 Months Post-baseline (Self Report)

    Time frame: Baseline, 3 months

    Number of days of prescription amphetamine use not as prescribed in past 2 weeks, as reported by survivor. Range: 0 to 14.

  23. Change in Survivor Methamphetamine Use Frequency at 3 Months Post-baseline (Self Report)

    Time frame: Baseline, 3 months

    Number of days of methamphetamine use in past 2 weeks, as reported by survivor. Range: 0 to 14.

  24. Change in Survivor Cigarette Use Frequency at 3 Months Post-baseline (Self Report)

    Time frame: Baseline, 3 months

    Number of days of cigarette use in past 2 weeks, as reported by survivor. Range: 0 to 14.

  25. Change in Survivor Cigarette Use Quantity at 3 Months Post-baseline (Self Report)

    Time frame: Baseline, 3 months

    Number of cigarettes smoked in a typical day in past 2 weeks, as reported by survivor.

Other outcomes

  1. Survivor Disclosure Frequency to Supporter at 1 Month Post-baseline (Informant Report)

    Time frame: 1 month

    Single item representing frequency of survivor's disclosures to supporter in past month, completed by supporter, adapted from the Early Intervention Clinic Disclosure Scale. Participants were instructed to enter a numerical value corresponding to number of disclosures. Higher scores indicate more frequent disclosure.

  2. Supporter Negative Reactions to Disclosure at 1 Month Post-baseline (Self Report)

    Time frame: 1 month

    Sum score on Negative Reactions subscale of the Social Reactions Questionnaire - Shortened, completed by supporter in reference to supporter's reactions to survivor in past month. Range: 0 to 48; higher scores indicate more frequent negative reactions.

  3. Supporter Positive Reactions to Disclosure at 1 Month Post-baseline (Self Report)

    Time frame: 1 month

    Sum score on Positive Reactions subscale of the Social Reactions Questionnaire - Shortened, completed by supporter in reference to supporter's reactions to survivor in past month. Range: 0 to 16; higher scores indicate more frequent positive reactions.

  4. Survivor Perceived Cultural Responsiveness of Intervention at 1 Month Post-baseline (Self Report)

    Time frame: 1 month

    Sum score on survey created for this study, completed by survivor. Range: 4 to 16; higher scores indicate greater perceived cultural responsiveness of intervention.

  5. Supporter Perceived Cultural Responsiveness of Intervention at 1 Month Post-baseline (Self Report)

    Time frame: 1 month

    Sum score on survey created for this study, completed by survivor. Range: 4 to 16; higher scores indicate greater perceived cultural responsiveness of intervention.

  6. Survivor Perceived Impact of Intervention at 1 Month Post-baseline (Self-report)

    Time frame: 1 month

    Sum score on survey created for this study, completed by survivor. Range: 4 to 20; higher scores indicate greater perceived impact of intervention.

  7. Supporter Perceived Impact of Intervention at 1 Month Post-baseline (Self-report)

    Time frame: 1 month

    Sum score on survey created for this study, completed by supporter. Range: 4 to 20; higher scores indicate greater perceived impact of intervention.

  8. Change in Supporter Typical Alcohol Consumption (Quantity) at 3 Months Post-baseline (Self Report)

    Time frame: Baseline, 3 months

    Number of typical drinks per week in past month reported by supporter on the Daily Drinking Questionnaire. Range: 0 to 7.

  9. Change in Supporter Typical Alcohol Consumption (Frequency) at 3 Months Post-baseline (Self Report)

    Time frame: Baseline, 3 months

    Number of typical drinking days per week in past month reported by supporter on the Daily Drinking Questionnaire. Range: 0 to 7.

  10. Change in Supporter Typical Alcohol Consumption (Hours) at 3 Months Post-baseline (Self Report)

    Time frame: Baseline, 3 months

    Number of typical drinking hours per week in past month reported by supporter on the Daily Drinking Questionnaire.

  11. Change in Supporter Cannabis Use Frequency at 3 Months Post-baseline (Self Report)

    Time frame: Baseline, 3 months

    Number of days of cannabis use in past 2 weeks, as reported by supporter. Range: 0 to 14.

  12. Change in Supporter Prescription Opioid Misuse Frequency at 3 Months Post-baseline (Self Report)

    Time frame: Baseline, 3 months

    Number of days of prescription opioid use not as prescribed in past 2 weeks, as reported by supporter. Range: 0 to 14.

  13. Change in Supporter Non-prescription Opioid Use Frequency at 3 Months Post-baseline (Self Report)

    Time frame: Baseline, 3 months

    Number of days of non-prescription opioid use in past 2 weeks, as reported by supporter. Range: 0 to 14.

  14. Change in Supporter Prescription Amphetamine Misuse Frequency at 3 Months Post-baseline (Self Report)

    Time frame: Baseline, 3 months

    Number of days of prescription amphetamine use not as prescribed in past 2 weeks, as reported by supporter. Range: 0 to 14.

  15. Change in Supporter Methamphetamine Use Frequency at 3 Months Post-baseline (Self Report)

    Time frame: Baseline, 3 months

    Number of days of methamphetamine use in past 2 weeks, as reported by supporter. Range: 0 to 14.

  16. Change in Supporter Cigarette Use Frequency at 3 Months Post-baseline (Self Report)

    Time frame: Baseline, 3 months

    Number of days of cigarette use in past 2 weeks, as reported by supporter. Range: 0 to 14.

  17. Change in Supporter Cigarette Use Quantity at 3 Months Post-baseline (Self Report)

    Time frame: Baseline, 3 months

    Number of cigarettes smoked in a typical day in past 2 weeks, as reported by supporter.

Sponsors and collaborators

Lead sponsor

University of Washington

Other

Registry information

Official study title

Improving Social Support Quality Among Survivors Seeking Acute Post-Rape Care: Testing a Supporter-Targeted Intervention

Acronym: CARE

Important dates

Study start
2022
Primary completion
2024
Study completion
2024
First posted
Apr 25, 2022
Registry last updated
Jun 8, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.